RodrÃguez-AgustÃn, A.; Casanova, V.; Grau-Expósito, J.; Sánchez-Palomino, S.; AlcamÃ, J.; Climent, N.
Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging. Pharmaceutics 2023, 15, 917.
https://doi.org/10.3390/pharmaceutics15030917
AMA Style
RodrÃguez-AgustÃn A, Casanova V, Grau-Expósito J, Sánchez-Palomino S, Alcamà J, Climent N.
Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging. Pharmaceutics. 2023; 15(3):917.
https://doi.org/10.3390/pharmaceutics15030917
Chicago/Turabian Style
RodrÃguez-AgustÃn, Andrea, VÃctor Casanova, Judith Grau-Expósito, Sonsoles Sánchez-Palomino, José AlcamÃ, and Núria Climent.
2023. "Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging" Pharmaceutics 15, no. 3: 917.
https://doi.org/10.3390/pharmaceutics15030917
APA Style
RodrÃguez-AgustÃn, A., Casanova, V., Grau-Expósito, J., Sánchez-Palomino, S., AlcamÃ, J., & Climent, N.
(2023). Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging. Pharmaceutics, 15(3), 917.
https://doi.org/10.3390/pharmaceutics15030917